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The intestinal microbiome is deﬁned as the assembly of genomes from microorganisms
inhabiting the gut. This microbial ecosystem regulates important functions of the host and
its correct composition and functionality is essential for a “healthy status.” Metagenomic
studies have highlighted variations of the intestinal microbiota as a function of age and diet.
Colonization of the infant gut starts at birth and is inﬂuenced by feeding habits (formula vs.
breast-feeding), birth mode and antibiotic exposure. The intestinal microbiota of full-term
vaginally delivered breast-fed infants is considered the gold-standard, representing the
reference for studies of alterations in other pediatric populations. At 2–3 years of age, the
intestinal microbiota reaches a composition similar to adults, remaining without noticeable
variations until senescence, when microbial instability and changes reappear. Here we
summarize the current knowledge on intestinal microbiota alterations at extreme stages
of life and tools for designing differentiated nutritional strategies by the use of probiotics,
prebiotics and speciﬁc nutrients in order to restore a balanced microbiota and to improve
immune and nutritional status.
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INTRODUCTION
It is increasingly clear that the gut microbiota is essential for
maintaining health. Until recently its role in human health had
remained largely unknown, mainly due to the lack of meth-
ods to study unculturable microorganisms, which constitute a
large fraction of the gut microbiota. However, in recent years the
development of next generation sequencing (NGS) methods has
facilitated the performance of metagenomic studies to determine
gut microbiome composition. These methods, together with the
use of gnotobiotic animals have demonstrated the importance
of the microbiota for host health, providing the basis for the
use of dietary interventions aimed at counteracting microbiota
aberrancies.
Next generation sequencing have indicated that, in spite of
a high inter-individual variability, human intestinal bacterial
populations of adults can be classiﬁed into three robust clus-
ters called “enterotypes,” dominated by Bacteroides, Prevotella,
and Ruminococcus (Arumugam et al., 2011). These enterotypes
seem independent of nationality, age, gender, and body mass
index but are inﬂuenced by long-term dietary habits (Wu et al.,
2011). In addition, some microbiota alterations are associated
with different human diseases (Turnbaugh et al., 2009; Qin et al.,
2010; Karlsson et al., 2013). However, to date most of the
larger studies have focused on adult populations and we are
still far from clearly understanding as to how the microbiota
affects health at different life stages. Interestingly, whilst the
microbiota shows a high stability and resilience to change dur-
ing adult life, it seems to be far more unstable at early infancy and
senescence.
The initial steps of microbiota establishment in the new-
born are critical for a proper development (El Aidy et al., 2013;
Borre et al., 2014), and may be affected by several factors
(Johnson and Versalovic, 2012). During the initial coloniza-
tion the microbiota suffers microbial succession phenomena
and is unstable (Yatsunenko et al., 2012). Similarly, at senes-
cence the microbiota suffers new changes, becoming unsta-
ble again (Claesson et al., 2011, 2012; Salazar et al., 2013).
Therefore, it is at these extremes of life where strategies aim-
ing at microbiome modulation may have a deeper impact on
health.
CULTURE INDEPENDENT AND OMIC TECHNIQUES FOR THE
STUDY OF THE INTESTINAL MICROBIOTA
Most studies on the intestinal microbiota have focused on
microbial communities and their variation among human sub-
groups, in order to deﬁne which microorganisms are in the
gut and how their presence/absence correlates with human
health. Compositional variation can be detected through poly-
merase chain reaction-denaturing gradient gel electrophoresis
(PCR-DGGE) of 16S rRNA gene, coupled to Sanger sequenc-
ing (Huipeng et al., 2014). Fluorescence in situ hybridization
(FISH) and quantitative PCR (qPCR) also allow quantiﬁcation
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of selected bacteria in mixed populations, but requires design
of probes/primers and therefore cannot detect unknown or low
abundance microbial groups. Therefore, total 16S rRNA gene
sequencing through NGS platforms (454-Pyrosequencing, MiSeq,
Ion Torrent, or SOLID) is becoming the gold-standard for over-
coming the limitations of the aforementioned methods. NGS
platforms are improving to offer cheaper alternatives and bet-
ter resolution to detect unculturable, unknown and low frequent
bacteria (Claesson et al., 2011; Fouhy et al., 2012; Mitra et al.,
2013). Signiﬁcant bioinformatic efforts are required to ana-
lyze the millions of reads generated through NGS. Alternative
high-throughput methods include oligonucleotide microarrays
(PhyloChip, Microbiota Array, HuGChip, and HITChip), that
determine the presence and abundance of thousands of phylo-
types in a sample (Paliy and Agans, 2012; Tottey et al., 2013)
although de novo probe design, optimization and validation is
time consuming (van den Bogert et al., 2011). Microarray and
NGS showed good correlation though minor differences may
appear depending, among other factors, on the origin of sam-
ples and number of 16S rRNA gene copies. Both techniques
can be complementary: microarray technology is a power-
ful method for routine study of many samples whereas NGS
enables a detailed understanding of microbial gene diversity
(Roh et al., 2010).
Current efforts focus on shotgun metagenomic sequencing to
generate comprehensive gene catalogs reﬂecting what metabolic
functionalities the intestinal microbiota encodes (Qin et al., 2010;
Cotillard et al., 2013; Rampelli et al., 2013). Despite the large
compositional variation among healthy individuals, distribution
of functionality is more conserved, suggesting that microbiota
metabolic potential might be more relevant than its taxonomi-
cal composition. Metagenomics also revealed activities exclusive
from gut environments and provided the basis to describe new
vitamins synthesis and signaling pathways (Jones et al., 2008).
Moreover, shotgun sequencing coupled with in vitro enrich-
ment cultures from fecal samples, allowed complete genomes
assembly of unculturable methanogenic archaeons, demonstrat-
ing that low frequency bacteria encode functionalities that might
be relevant in the cross-talk between microbiota and host (Bor-
rel et al., 2012; Luo et al., 2012). Functional microarrays are also
available such as the CAZymes Chip that detects thousands of car-
bohydrate degrading activities encoded by a microbiota sample
(El Kaoutari et al., 2013).
What gut microbes are actually doing can be investigated
through a combination of metatranscriptomics, metaproteomics,
and metabolomics approaches to analyze RNA, protein and small
metabolite pools from feces (Gosalbes et al., 2011; Marcobal
et al., 2013; Franzosa et al., 2014; Ursell et al., 2014), which
are subsequently identiﬁed by comparison against appropriate
databases. Comprehension of the role that human microbiota
plays in health and disease requires integration of taxonomical
and metabolic features as well as the understanding of the cross-
talk between microbiota and host. Metabolomics provide the basis
to evaluate dietary intervention’s effects on gutmicrobiota compo-
sition/functionality and host metabolic outcomes (Marcobal et al.,
2013; Daniel et al., 2014). Development of computational tools to
integrate results from multiple levels still remains a challenge.
INTESTINAL MICROBIOTA, IMMUNE SYSTEM, AND
NUTRITIONAL STATUS THROUGHOUT LIFE
NEWBORNS
Traditionally, it was thought thatmicrobial colonization of the gas-
trointestinal tract begins immediately after birth. Recent studies
have shown the presence of microorganisms in placenta, amni-
otic ﬂuid, umbilical cord blood, and meconium (Jiménez et al.,
2005; DiGiulio, 2012; Moles et al., 2013; Aagaard et al., 2014).
The classical pattern of early microbial development involves a
ﬁrst colonization by facultative anaerobes, which deplete the ini-
tial oxygen supplies creating a more suitable environment for
the subsequent colonization by strict anaerobes (Fanaro et al.,
2003). From an initial low diversity and complexity the intesti-
nal microbiota reaches a stable population similar to that of an
adult around 2–3 years of age (Koenig et al., 2011; Yatsunenko
et al., 2012). The microbial population established in the initial
stages of life has a profound impact on epigenetic programming
and future homeostasis and well-being of the individual (Palmer
et al., 2007; Canani et al., 2011). In this way, it is known that
maternal and neonatal under-nutrition may promote an inade-
quate gut microbiota composition and functionality, accounting
for deviant programming of later immunity and of regulation
of genes involved in lipid and carbohydrate metabolism (Canani
et al., 2011; Kerperien et al., 2012).
Several factors inﬂuence the establishment and composition of
the infant intestinal microbiota: feeding type, delivery mode, ges-
tational age or the use of antibiotics, among others (Penders et al.,
2006). Breast milk is considered the optimal feeding pattern for
newborns and the WHO recommends exclusive breast-feeding up
to 6 months of age and then supplemental breast-feeding up to
2 years of age (WHO, 2009). Short- and long-term health beneﬁts
associated with breast-feeding have been reported and breast-
fed infants are considered healthier, showing lower incidence
of enteric and non-enteric infections, necrotizing enterocolitis
(NEC), allergy and atopic disorders or diabetes compared with
formula-fed infants (Le Huerou-Luron et al., 2010). Breast milk
contains a wide range of protective compounds including carbo-
hydrates (such as oligosaccharides with strong prebiotic activity
and ability to displace pathogens), nucleotides, immunoglobulins,
cytokines, short chain fatty acids (SCFA), and lactoferrin, and is a
source of beneﬁcial bacteria (Marques et al., 2010; Solís et al., 2010;
Bode, 2012). The intestine of breast-fed infants was traditionally
considered to be dominated by biﬁdobacteria but recent stud-
ies using high-throughput 16S rDNA techniques demonstrated
that Proteobacteria dominate the infant intestinal microbiota
(Arboleya et al., 2012a; Fan et al., 2014). However, breast-fed
infants presented higher levels and abundance of biﬁdobacteria
and lower levels of potential pathogens than formula-fed babies,
in which a more diverse microbiota dominated by Bacteroides and
Clostridia resides, with higher levels of Klebsiella (Fallani et al.,
2010; Bezirtzoglou et al., 2011). Differential patterns of SCFA pro-
duction have been found in breast-fed vs. formula-fed infants
(Le Huerou-Luron et al., 2010; Arboleya et al., 2012b). Weaning
promoted higher levels of Bacteroidetes and Firmicutes as well
as functional genes characteristic of adult microbiome whereas it
decreases Biﬁdobacteria and Proteobacteria (Fallani et al., 2011;
Koenig et al., 2011). The establishment of the so-called human
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“enterotypes” seems to start around 18 months, although at
this early age these enterotypes are still susceptible to shifting
(Bergstrom et al., 2014).
ADULTS
The human gut microbiota reaches its maximum complexity at
adolescence following a gradual increase in the phylogenetic diver-
sity of themicrobiomeduring adulthood. The gut of healthy adults
is populated by around 1014 bacteria which outnumber the total
eukaryotic cells of the human body. This ecosystem is dominated
by the phyla Bacteroidetes and Firmicutes while Actinobacteria,
Proteobacteria, andVerrucomicrobia are represented in lower per-
centages (Arumugam et al., 2011). In addition to bacterial and
eukaryotic cells, themain representative of Archaea in the adult gut
is the methanogenic species Methanobrevibacter smithii (Eckburg
et al., 2005).
The human microbiome contributes to shaping the immune
system and should not be underestimated as a key factor in
the maintenance of human health, being a key player in vita-
min production, digestion, energy homeostasis, angiogenesis and
maintenance of intestinal barrier integrity. The human gut micro-
biota appears altered in several disease states including obesity,
inﬂammatory bowel disease and irritable bowel syndrome. The
responses of the microbiota to antibiotic treatment can vary
depending on individuals and is inﬂuenced by the prior exposure
and the type of antibiotic used (Sullivan et al., 2001).
The “adult-like” gut microbiota ecosystem maintains a high
stability and homeostasis in the absence of signiﬁcant ecological
stressors but intestinal dysbiosis appears with the old age.
ELDERLY
Aging has been deﬁned as “the regression of physiological func-
tion accompanied by advancement of age” (Woodmansey, 2007)
and is associated with physiological changes in the gastrointesti-
nal tract, as well as changes in dietary patterns and immune
function. Aging is intimately linked with a decline in the nor-
mal function of the immune system (Haq and McElhaney,
2014) which results in an increased vulnerability of individu-
als against common infections (immunosenescence). Although
physiological phenomena linked to aging vary among people
and is inﬂuenced by external factors, according to the WHO
most westernized countries have accepted the chronological age
of 65 years as a deﬁnition of “elderly.” Malnutrition is a clas-
sical feature of old age and is linked to physiological changes
that impact food digestion and absorption. Increased thresh-
old for taste and smell, swallowing difﬁculties and masticatory
dysfunction in the elderly can result in nutritionally imbal-
anced diets. Elderly people also suffer from atrophic gastritis
with a decreased absorption of calcium, ferric iron, and vitamin
B12 (Biagi et al., 2012). In addition, reduced intestinal motil-
ity leads to fecal impaction and constipation and an increased
intestinal transit time is linked with reduced bacterial excre-
tion and augmentation of bacterial protein fermentation, which
consequently alters the gut fermentative process (Biagi et al.,
2012).
The imbalance between pro-inﬂammatory and anti-inﬂam-
matory status in aged people results in a low-grade chronic
systemic inﬂammation known as “inﬂammaging.” Inﬂammag-
ing contributes to frailty, which is considered a hallmark of
unhealthy aging, and degenerative disorders (Biagi et al., 2012).
Themain changes in the immune system include reduced humoral
responses, decreases in dendritic cells efﬁciency to activate T and
B cell populations, declination in the generation of new naive
T and B cells, and reduced natural killer cell activity (Vallejo,
2011). Also augmented levels of pro-inﬂammatory cytokines such
as TNF-α, IL12 and the chemokine IL8, and a reduction inNK cells
cytotoxic activity have been reported (Salazar et al., 2013). These
alterations contribute to the prevalence of cancer, autoimmune
and chronic diseases such as Alzheimer’s disease, atherosclerosis,
osteoarthritis and insulin resistance (Haq and McElhaney, 2014).
The origins and drivers of the age-related chronic inﬂammation
are not entirely clear but there is a growing body of evidence
suggesting the role of the age-related intestinal microbiota in
inﬂammaging.
The core microbiota composition of elderly individuals signif-
icantly differs from healthy adults and the set of microbial genes
required for the proper maintenance of the gut homeostasis is
likely to be different than that required for younger populations
(Qin et al., 2010). The abundance of the members of the dominant
phyla of the gut microbiota, Firmicutes and Bacteroidetes in elders
is controversial and seems to be country dependent (Biagi et al.,
2012). Ahigher proportion of Bacteroidetes and a reduced stability
of the microbial community has been reported in the elderly Irish
population, whereas the proportion of Bacteroidetes remains con-
stant in Italian elderly (Biagi et al., 2013). The age-related intestinal
microbiota changes include a reduction in species diversity of most
bacterial groups which makes microbiota less resistant to major
ﬂuctuations in response to several environmental factors. Shifts in
the dominant species within several bacterial groups, decline in
beneﬁcial microorganisms, increase of facultative anaerobic bac-
teria and decrease in the availability of total SCFA have also been
described (Salazar et al., 2013). These modiﬁcations of the intesti-
nal microbiota may contribute to the establishment of a state
prone to disease and might increase the susceptibility to infec-
tions, such as those caused by Clostridium difﬁcile (Biagi et al.,
2012).
NUTRITIONAL STRATEGIES FOR RESTORING A BALANCED
MICROBIOTA AT EXTREME AGES OF LIFE
The microbiota of speciﬁc healthy human groups is considered a
reference to identify targets for intervention in order to promote
a balanced microbiota in populations at extreme ages of life. The
gold standard microbiota in infants is that of full-term vaginally
delivered breast-fed babies. Early stages of intestinal colonization
when the microbiota is still developing, is the key period to apply
modulation strategies. Identiﬁed alterations of the infant micro-
biota generally impact on microbial diversity, anaerobe/facultative
anaerobes ratio, incidence and levels of Enterobacteriaceae and
intestinal pathogens, SCFA production pattern, and function-
ality of metagenomes (Arboleya et al., 2012a,b,d). Lowering the
incidence and severity of NEC as well as the infection risk in pre-
mature infants is a target of relevance (Wang et al., 2009). The
main targets for nutritional intervention in order to restore a
balanced microbiota in newborns are summarized in Table 1.
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In the elderly, the microbiota of a younger population of healthy
adults otherwise sharing similar characteristics in terms of geo-
graphic location and diet as the older people is considered the
benchmark of healthy microbiota. This reference group must have
had a past socio-economic status as similar as possible to the
elders: a history of exposure to different environments in the two
populations may lead to attribute to aging, variations due to the
action of different environmental factors such as those linked to
social habits, nutritional patterns, or residence location (Claesson
et al., 2012; Salazar et al., 2013). Loss of the community-associated
microbiota, that is the set of microorganisms shared by individu-
als from a given social group, correlated with increased frailty. The
reduced levels of C. leptum and Blautia coccoides and the higher
incidence of C. difﬁcile infections are relevant targets (Salazar
et al., 2013; Power et al., 2014). Some nutritional deﬁciencies of
elders are related with lower intakes of speciﬁc nutrients which
are important for maintaining the immune and gastrointestinal
functions and which are a consequence of the general loss of func-
tionality of the gastrointestinal tract (González et al., 2013; Power
et al., 2014). Therefore, nutritional strategies in elders should con-
sider the intestinal microbiota, immune system, and nutritional
deﬁciencies (Table 1).
Different approaches have been proposed for restoring a bal-
ancedmicrobiota. Fecal transplantation is known frommany years
ago (Eiseman et al., 1958); although a renewed interest has arisen
in recent time, this alternative has currently important ethical
concerns and legal barriers (Ratner, 2014); however, it could be
considered as proof of principle research that would help to ﬁnd
a deﬁnite cocktail of strains to be administered as a corrective
measure of intestinal dysbiosis (Petrof et al., 2013).
Probiotics are “live microorganisms which when adminis-
tered in adequate amount confer a health beneﬁt on the host”
(FAO/WHO, 2006). The most used probiotics in foods are lac-
tobacilli and biﬁdobacteria. Probiotics may interact with the
intestinal microbiota, inhibit enteric pathogens and modulate the
immune system. Prebiotics are “selectively fermented ingredients
that result in speciﬁc changes in the composition and/or activ-
ity of the gastrointestinal microbiota, thus conferring beneﬁt(s)
upon host health” (Roberfroid et al., 2010). Prebiotics usually
are complex carbohydrates naturally present in vegetables and
other foods or can be industrially produced as ingredients. Their
beneﬁcial effects are linked to promotion of changes on the
composition and metabolic activity of the intestinal microbiota
(Roberfroid et al., 2010). The inclusion of probiotics and pre-
biotics in foods has been extensively used for modulating the
gut microbiota. However, to date the speciﬁc needs of deﬁned
target populations, such as the extremes of life, in terms of
microbiota modulation have not been taken into account for
probiotic or prebiotic selection and products formulation. A
schematic representation of the steps involved in designing nutri-
tional intervention strategies for human extreme ages is provided
in Figure 1.
INTEGRATED PERSPECTIVE AND FUTURE TRENDS OF THE
HUMAN INTESTINAL MICROBIOTA AND DIET
The development of dietary intervention strategies speciﬁcally tar-
geted to populations at the extreme ages of life, may constitute an
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FIGURE 1 | Schematic representation of the steps involved in designing
nutritional interventions to improve functionality of specific human
population groups in the extreme ages of life: (newborns and elders).
Step 1: deﬁning reference populations for comparative studies. Step 2:
identifying intestinal and extraintestinal targets for intervention. Step 3:
proving functional efﬁcacy of different nutritional strategies.
interesting approach (Arboleya et al., 2012c). A number of stud-
ies support the beneﬁts of speciﬁc probiotics and prebiotics in
adults (Power et al., 2014), although the evidence is still scarce
in infants and elders. Several studies indicate that prebiotics may
be effective in decreasing the rate of overall infections in infants
(Lohner et al., 2014) and that maternal probiotic supplementa-
tion may decrease the incidence of NEC in breastfed preterm
babies (Benor et al., 2014). However, there is still a need for long-
term follow-up of initiated probiotic studies to assess the impact
of early life interventions for late efﬁcacy (Videhult et al., 2014).
Therefore, the selection of probiotics and prebiotics included in
tailor-made foods for human populations at extreme ages of life
and targeting well deﬁned microbiota alterations, is a key future
action (Aggett et al., 2003; Adlerberth and Wold, 2009; Duncan
and Flint, 2013). This is pointed out by recent reports underlin-
ing a high inter-individual variability in the response to probiotics
(van Baarlen et al., 2011; Grzeskowiak et al., 2012) and important
differences in the effect of the same probiotics and prebiotics on
the intestinal microbiota from different human groups (Arboleya
et al., 2013).
Moreover, considering the wide impact of the microbiota on
host physiology it may be time for addressing new targets such as
the age-related chronic-inﬂammation (Macpherson and Harris,
2004) or the maintenance or correct development of cognitive
function in elders and preterm babies, respectively (Gilbert et al.,
2013). In addition, these population groups may require speciﬁc
and nutritionally adequate products able to satisfy their particular
requirements. Such knowledge should now be integrated into the
development of a new generation of highly adapted functional
food products.
ACKNOWLEDGMENTS
Spanish authors acknowledge the support from the Plan Nacional
and Plan Estatal de I+D (Ministry of Economy and Competitive-
ness) through the projects AGL2010-16525 and AGL2013-43770-
R, respectively. Irish authors were funded by Science Foundation
Ireland-funded Centre for Science, Engineering and Technology,
the Alimentary Pharmabiotic Centre.
REFERENCES
Aagaard, K., Ma, J., Antony, K. M., Ganu, R., Petrosino, J., and Versalovic, J. (2014).
The placenta harbors a unique microbiome. Sci. Transl. Med. 6:237ra265. doi:
10.1126/scitranslmed.3008599
Adlerberth, I., and Wold, A. E. (2009). Establishment of the gut microbiota in West-
ern infants. Acta Paediatr. 98, 229–238. doi: 10.1111/j.1651-2227.2008.01060.x
Frontiers in Genetics | Nutrigenomics November 2014 | Volume 5 | Article 406 | 6
Salazar et al. Intestinal microbiome at extreme ages
Aggett, P. J., Agostoni, C., Axelsson, I., Edwards, C. A., Goulet, O., Hernell, O., et al.
(2003). Nondigestible carbohydrates in the diets of infants and young children: a
commentary by the ESPGHANCommittee onNutrition. J. Pediatr. Gastroenterol.
Nutr. 36, 329–337. doi: 10.1097/00005176-200303000-00006
Arboleya, S., Ang, L., Margolles, A., Yiyuan, L., Dongya, Z., Liang, X.,
et al. (2012a). Deep 16S rRNA metagenomics and quantitative PCR analy-
ses of the premature infant fecal microbiota. Anaerobe 18, 378–380. doi:
10.1016/j.anaerobe.2012.04.013
Arboleya, S., Binetti, A., Salazar, N., Fernández, N., Solís, G., Hernández-
Barranco, A., et al. (2012b). Establishment and development of intestinal
microbiota in preterm neonates. FEMS Microbiol. Ecol. 79, 763–772. doi:
10.1111/j.1574-6941.2011.01261.x
Arboleya, S., Gonzalez, S., Salazar, N., Ruas-Madiedo, P., de los Reyes-Gavilan, C. G.,
and Gueimonde, M. (2012c). Development of probiotic products for nutritional
requirements of speciﬁc human populations. Eng. Life Sci. 12, 368–376. doi:
10.1002/elsc.201100129
Arboleya, S., Solís, G., Fernández, N., de los Reyes-Gavilán, C. G., and
Gueimonde, M. (2012d). Facultative to strict anaerobes ratio in the preterm
infant microbiota: a target for intervention? Gut Microbes 3, 583–588. doi:
10.4161/gmic.21942
Arboleya, S., Salazar, N., Solís, G., Fernández, N., Hernández-Barranco, A. M.,
Cuesta, I., et al. (2013). Assessment of intestinal microbiota modulation ability
of Biﬁdobacterium strains in in vitro fecal batch cultures from preterm neonates.
Anaerobe 19, 9–16. doi: 10.1016/j.anaerobe.2012.11.001
Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., et al.
(2011). Enterotypes of the human gut microbiome. Nature 473, 174–180. doi:
10.1038/nature09944
Azad, M. B., Konya, T., Maughan, H., Guttman, D. S., Field, C. J., Chari, R. S., et al.
(2013). Gut microbiota of healthy Canadian infants: proﬁles by mode of delivery
and infant diet at 4 months. CMAJ 185, 385–394. doi: 10.1503/cmaj.121189
Barrett, E., Kerr, C., Murphy, K., O’Sullivan, O., Ryan, C. A., Dempsey, E.
M., et al. (2013). The individual-speciﬁc and diverse nature of the preterm
infant microbiota. Arch. Dis. Child. Fetal Neonatal Ed. 98, F334–F340. doi:
10.1136/archdischild-2012-303035
Begega, A., Méndez Lopez, M., De Iscar, M. J., Cuesta-Izquierdo, M., Solís,
G., Fernández-Colomer, B., et al. (2010). Assessment of the global intelligence
and selective cognitive capacities in preterm 8-year-old children. Psicothema 22,
648–653.
Benor, S., Marom, R., Ben Tov, A., Domany, K. A., Zaidenbeg-Israeli, G., and
Dollberg, S. (2014). Probiotic supplementation in mothers of very low birth
weight infants. Am. J. Perinatol. 31, 497–503. doi: 10.1055/s-0033-1353490
Bergstrom, A., Skov, T. H., Bahl, M. I., Roager, H. M., Christensen, L. B., Ejlerskov,
K. T., et al. (2014). Establishment of intestinal microbiota during early life: a
longitudinal, explorative study of a large cohort of Danish infants. Appl. Environ.
Microbiol. 80, 2889–2900. doi: 10.1128/AEM.00342-14
Bezirtzoglou, E., Tsiotsias, A., and Welling, G. W. (2011). Microbiota proﬁle in feces
of breast- and formula-fed newborns by using ﬂuorescence in situ hybridization
(FISH). Anaerobe 17, 478–482. doi: 10.1016/j.anaerobe.2011.03.009
Biagi, E., Candela, M., Fairweather-Tait, S., Franceschi, C., and Brigidi, P. (2012).
Aging of the human metaorganism: the microbial counterpart. Age (Dordr.) 34,
247–267. doi: 10.1007/s11357-011-9217-5
Biagi, E., Candela, M., Turroni, S., Garagnani, P., Franceschi, C., and Brigidi,
P. (2013). Ageing and gut microbes: perspectives for health maintenance and
longevity. Pharmacol. Res. 69, 11–20. doi: 10.1016/j.phrs.2012.10.005
Biasucci, G., Rubini, M., Riboni, S., Morelli, L., Bessi, E., and Retetangos, C. (2010).
Mode of delivery affects the bacterial community in the newborn gut. Early. Hum.
Dev. 86(Suppl. 1), 13–15. doi: 10.1016/j.earlhumdev.2010.01.004
Bode, L. (2012). Human milk oligosaccharides: every baby needs a sugar mama.
Glycobiology 22, 1147–1162. doi: 10.1093/glycob/cws074
Borre, Y. E., O’Keeffe, G. W., Clarke, G., Stanton, C., Dinan, T. G., and Cryan,
J. F. (2014). Microbiota andneurodevelopmentalwindows: implications for brain
disorders. Trends Mol. Med. 20, 509–518. doi: 10.1016/j.molmed.2014.05.002
Borrel, G., Harris, H. M., Tottey, W., Mihajlovski, A., Parisot, N., Peyretail-
lade, E., et al. (2012). Genome sequence of “Candidatus Methanomethylophilus
alvus” Mx1201, a methanogenic archaeon from the human gut belonging to a
seventh order of methanogens. J. Bacteriol. 194, 6944–6945. doi: 10.1128/JB.
01867-12
Canani, R. B., Di Costanzo, M., Leone, L., Bedogni, G., Brambilla, P., Cianfarani, S.,
et al. (2011). Epigenetic mechanisms elicited by nutrition in early life. Nutr. Res.
Rev. 24, 198–205. doi: 10.1017/s0954422411000102
Claesson,M. J., Cusack, S., O’Sullivan,O., Greene-Diniz, R., DeWeerd,H., Flannery,
E., et al. (2011). Composition, variability, and temporal stability of the intestinal
microbiota of the elderly. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1), 4586–4591.
doi: 10.1073/pnas.1000097107
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S.,
et al. (2012). Gut microbiota composition correlates with diet and health in the
elderly. Nature 488, 178–184. doi: 10.1038/nature11319
Cotillard, A., Kennedy, S. P., Kong, L. C., Prifti, E., Pons, N., Le Chatelier, E., et al.
(2013). Dietary intervention impact on gut microbial gene richness. Nature 500,
585–588. doi: 10.1038/nature12480
Daniel, H., Moghaddas Gholami, A., Berry, D., Desmarchelier, C., Hahne, H., Loh,
G., et al. (2014). High-fat diet alters gut microbiota physiology in mice. ISME J.
8, 295–308. doi: 10.1038/ismej.2013.155
DiGiulio,D. B. (2012). Diversity of microbes in amniotic ﬂuid. Semin. FetalNeonatal
Med. 17, 2–11. doi: 10.1016/j.siny.2011.10.001
Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G.,
Fierer, N., et al. (2010). Delivery mode shapes the acquisition and structure of the
initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad.
Sci. U.S.A. 107, 11971–11975. doi: 10.1073/pnas.1002601107
Duncan, S. H., and Flint, H. J. (2013). Probiotics and prebiotics and health
in ageing populations. Maturitas 75, 44–50. doi: 10.1016/j.maturitas.2013.
02.004
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent,
M., et al. (2005). Diversity of the human intestinal microbial ﬂora. Science 308,
1635–1638. doi: 10.1126/science.1110591
Eiseman, B., Silen, W., Bascom, G. S., and Kauvar, A. J. (1958). Fecal enema as
an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44,
854–859.
El Aidy, S., Hooiveld, G., Tremaroli, V., Bäckhed, F., and Kleerebezem, M. (2013).
The gut microbiota and mucosal homeostasis: colonized at birth or at adulthood,
does it matter? Gut Microbes 4, 118–124. doi: 10.4161/gmic.23362
El Kaoutari, A., Armougom, F., Leroy, Q., Vialettes, B., Million, M., Raoult, D.,
et al. (2013). Development and validation of a microarray for the investigation of
the CAZymes encoded by the human gut microbiome. PLoS ONE 8:e84033. doi:
10.1371/journal.pone.0084033
Fallani, M., Amarri, S., Uusijarvi, A., Adam, R., Khanna, S., Aguilera,
M., et al. (2011). Determinants of the human infant intestinal microbiota
after the introduction of ﬁrst complementary foods in infant samples from
ﬁve European centres. Microbiology 157, 1385–1392. doi: 10.1099/mic.0.
042143-0
Fallani, M., Young, D., Scott, J., Norin, E., Amarri, S., Adam, R., et al. (2010).
Intestinal microbiota of 6-week-old infants across Europe: geographic inﬂuence
beyond delivery mode, breast-feeding, and antibiotics. J. Pediatr. Gastroenterol.
Nutr. 51, 77–84. doi: 10.1097/MPG.0b013e3181d1b11e
Fan, W., Huo, G., Li, X., Yang, L., and Duan, C. (2014). Impact of diet in shaping
gut microbiota revealed by a comparative study in infants during the six months
of life. J. Microbiol. Biotechnol. 24, 133–143. doi: 10.4014/jmb.1309.09029
Fanaro, S., Chierici, R., Guerrini, P., and Vigi, V. (2003). Intestinal microﬂora in
early infancy: composition and development. Acta Paediatr. Suppl. 91, 48–55.
FAO/WHO. (2006). Probiotics in Food: Health and Nutritional Properties and Guide-
lines for Evaluation. FAO Food and Nutrition Paper 85. Food and Agriculture
Organization of theUnitedNations andWorldHealthOrganization,Rome. Avail-
able at: ftp://ftp.fao.org/docrep/fao/009/a0512e/a0512e00.pdf [accessed April 3,
2008].
Fouhy, F., Ross, R. P., Fitzgerald, G. F., Stanton, C., and Cotter, P. D. (2012). Compo-
sition of the early intestinal microbiota: knowledge, knowledge gaps and the use
of high-throughput sequencing to address these gaps. Gut Microbes 3, 203–220.
doi: 10.4161/gmic.20169
Franzosa, E. A., Morgan, X. C., Segata, N., Waldron, L., Reyes, J., Earl, A. M., et al.
(2014). Relating the metatranscriptome and metagenome of the human gut. Proc.
Natl. Acad. Sci. U.S.A. 111, E2329–E2338. doi: 10.1073/pnas.1319284111
Gilbert, K., Gire, R., and Rousseau, G. (2013). Probiotics and Gut-Brain Axis:
promising area in well-being. Agro Food Ind. Hi Tech 24, 6–9.
Goldani, H. A., Bettiol, H., Barbieri, M. A., Silva, A. A., Agranonik, M., Morais,
M. B., et al. (2011). Cesarean delivery is associated with an increased risk of
www.frontiersin.org November 2014 | Volume 5 | Article 406 | 7
Salazar et al. Intestinal microbiome at extreme ages
obesity in adulthood in a Brazilian birth cohort study. Am. J. Clin. Nutr. 93,
1344–1347. doi: 10.3945/ajcn.110.010033
González, S., López, P., Margolles, A., Suárez, A., Patterson, A. M., Cuervo, A., et al.
(2013). Fatty acids intake and immune parameters in the elderly. Nutr. Hosp. 28,
474–478. doi: 10.3305/nh.2013.28.2.6183
Gosalbes, M. J., Durbán, A., Pignatelli, M., Abellan, J. J., Jiménez-Hernández,
N., Pérez-Cobas, A. E., et al. (2011). Metatranscriptomic approach to
analyze the functional human gut microbiota. PLoS ONE 6:e17447. doi:
10.1371/journal.pone.0017447
Grzeskowiak, L., Gronlund, M. M., Beckmann, C., Salminen, S., Von Berg, A., and
Isolauri, E. (2012). The impact of perinatal probiotic intervention on gut micro-
biota: double-blind placebo-controlled trials in Finland and Germany. Anaerobe
18, 7–13. doi: 10.1016/j.anaerobe.2011.09.006
Haq, K., and McElhaney, J. E. (2014). Immunosenescence: inﬂuenza vaccination
and the elderly. Curr. Opin. Immunol. 29C, 38–42. doi: 10.1016/j.coi.2014.03.008
Huipeng,W., Lifeng, G., Chuang, G., Jiaying, Z., andYuankun, C. (2014). The differ-
ences in colonic mucosal microbiota between normal individual and colon cancer
patients by polymerase chain reaction-denaturing gradient gel electrophoresis.
J. Clin. Gastroenterol. 48, 138–144. doi: 10.1097/MCG.0b013e3182a26719
Imai, C. M., Gunnarsdottir, I., Thorisdottir, B., Halldorsson, T. I., and Thorsdottir, I.
(2014). Associations between infant feeding practice prior to sixmonths and body
mass index at six years of age. Nutrients 6, 1608–1617. doi: 10.3390/nu6041608
Jacquot, A., Neveu, D., Aujoulat, F., Mercier, G., Marchandin, H., Jumas-
Bilak, E., et al. (2011). Dynamics and clinical evolution of bacterial gut
microﬂora in extremely premature patients. J. Pediatr. 158, 390–396. doi:
10.1016/j.jpeds.2010.09.007
Jiménez, E., Fernández, L., Marín, M. L., Martín, R., Odriozola, J. M., Nueno-Palop,
C., et al. (2005). Isolation of commensal bacteria from umbilical cord blood of
healthy neonates born by cesarean section. Curr. Microbiol. 51, 270–274. doi:
10.1007/s00284-005-0020-3
Johnson, C. L., and Versalovic, J. (2012). The human microbiome and its potential
importance to pediatrics. Pediatrics 129, 950–960. doi: 10.1542/peds.2011-2736
Jones, B. V., Begley, M., Hill, C., Gahan, C. G., and Marchesi, J. R. (2008). Func-
tional and comparative metagenomic analysis of bile salt hydrolase activity in
the human gut microbiome. Proc. Natl. Acad. Sci. U.S.A. 105, 13580–13585. doi:
10.1073/pnas.0804437105
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergstrom, G., Behre, C. J.,
Fagerberg, B., et al. (2013). Gut metagenome in European women with nor-
mal, impaired and diabetic glucose control. Nature 498, 99–103. doi: 10.1038/
nature12198
Keller, J. M., and Surawicz, C. M. (2014). Clostridium difﬁcile infection in the elderly.
Clin. Geriatr. Med. 30, 79–93. doi: 10.1016/j.cger.2013.10.008
Kerperien, J., Schouten, B., Boehm, G., Willemsen, L. E. M., Garssen, J., Knippels,
L. M. J., et al. (2012). “Development of the immune system-early nutrition and
consequences for later life,” in Recent Advances in Immunology to Target Cancer,
Inﬂammation and Infections, ed. J. Kanwar (Rijeka: InTech Europe Press), 315–
334.
Koenig, J. E., Spor, A., Scalfone, N., Fricker, A. D., Stombaugh, J., Knight, R.,
et al. (2011). Succession of microbial consortia in the developing infant gut
microbiome. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1), 4578–4585. doi:
10.1073/pnas.1000081107
Le Huerou-Luron, I., Blat, S., and Boudry, G. (2010). Breast- v. formula-feeding:
impacts on the digestive tract and immediate and long-term health effects. Nutr.
Res. Rev. 23, 23–36. doi: 10.1017/S0954422410000065
Lohner, S., Kullenberg, D., Antes, G., Decsi, T., and Meerpohl, J. J. (2014).
Prebiotics in healthy infants and children for prevention of acute infectious
diseases: a systematic review and meta-analysis. Nutr. Rev. 72, 523–531. doi:
10.1111/nure.12117
Luo, C., Tsementzi, D., Kyrpides, N. C., and Konstantinidis, K. T. (2012). Individual
genome assembly from complex community short-read metagenomic datasets.
ISME J 6, 898–901. doi: 10.1038/ismej.2011.147
Macpherson, A. J., and Harris, N. L. (2004). Interactions between commensal
intestinal bacteria and the immune system. Nat. Rev. Immunol. 4, 478–485. doi:
10.1038/nri1373
Marcobal,A., Kashyap, P. C.,Nelson, T.A.,Aronov, P.A.,Donia,M. S., Spormann,A.,
et al. (2013). A metabolomic view of how the human gut microbiota impacts the
host metabolome using humanized and gnotobiotic mice. ISME J. 7, 1933–1943.
doi: 10.1038/ismej.2013.89
Marques, T. M., Wall, R., Ross, R. P., Fitzgerald, G. F., Ryan, C. A.,
and Stanton, C. (2010). Programming infant gut microbiota: inﬂuence of
dietary and environmental factors. Curr. Opin. Biotechnol. 21, 149–156. doi:
10.1016/j.copbio.2010.03.020
Mitra, S., Forster-Fromme, K., Damms-Machado, A., Scheurenbrand, T., Biskup, S.,
Huson, D. H., et al. (2013). Analysis of the intestinal microbiota using SOLiD 16S
rRNAgene sequencing andSOLiD shotgun sequencing. BMCGenomics 14(Suppl.
5):S16. doi: 10.1186/1471-2164-14-S5-S16
Moles, L., Gomez, M., Heilig, H., Bustos, G., Fuentes, S., De Vos, W., et al.
(2013). Bacterial diversity in meconium of preterm neonates and evolution of
their fecal microbiota during the ﬁrst month of life. PLoS ONE 8:e66986. doi:
10.1371/journal.pone.0066986
O’Sullivan, O., Coakley, M., Lakshminarayanan, B., Conde, S., Claesson, M. J.,
Cusack, S., et al. (2012). Alterations in intestinal microbiota of elderly Irish
subjects post-antibiotic therapy. J. Antimicrob. Chemother. 68, 214–221. doi:
10.1093/jac/dks348
Paliy, O., and Agans, R. (2012). Application of phylogenetic microarrays to
interrogation of human microbiota. FEMS Microbiol. Ecol. 79, 2–11. doi:
10.1111/j.1574-6941.2011.01222.x
Palmer, C., Bik, E. M., Digiulio, D. B., Relman, D. A., and Brown, P. O. (2007).
Development of the human infant intestinal microbiota. PLoS Biol. 5:e177. doi:
10.1371/journal.pbio.0050177
Penders, J., Thijs, C., Vink, C., Stelma, F. F., Snijders, B., Kummeling, I., et al. (2006).
Factors inﬂuencing the composition of the intestinal microbiota in early infancy.
Pediatrics 118, 511–521. doi: 10.1542/peds.2005-2824
Petrof, E. O., Gloor, G. B., Vanner, S. J., Weese, S. J., Carter, D., Daigneault, M. C.,
et al. (2013). Stool substitute transplant therapy for the eradication of Clostridium
difﬁcile infection: ‘RePOOPulating’ the gut. Microbiome 1:3. doi: 10.1186/2049-
2618-1-3
Power, S. E., O’Toole, P. W., Stanton, C., Ross, R. P., and Fitzgerald, G. F.
(2014). Intestinal microbiota, diet and health. Br. J. Nutr. 111, 387–402. doi:
10.1017/S0007114513002560
Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., et al. (2010).
A human gut microbial gene catalogue established by metagenomic sequencing.
Nature 464, 59–65. doi: 10.1038/nature08821
Rampelli, S., Candela, M., Turroni, S., Biagi, E., Collino, S., Franceschi, C., et al.
(2013). Functional metagenomic proﬁling of intestinal microbiome in extreme
ageing. Aging (Albany N. Y.) 5, 902–912.
Ratner, M. (2014). Fecal transplantation poses dilemma for FDA. Nat. Biotechnol.
32, 401–402. doi: 10.1038/nbt0514-401
Roberfroid, M., Gibson, G. R., Hoyles, L., Mccartney, A. L., Rastall, R.,
Rowland, I., et al. (2010). Prebiotic effects: metabolic and health beneﬁts. Br. J.
Nutr. 104(Suppl. 2), S1–S63. doi: 10.1017/S0007114510003363
Roh, S.W.,Abell, G. C. J., Kim, K.-H., Nam,Y.-D., and Bae, J.-W. (2010). Comparing
microarrays and next-generation sequencing technologies for microbial ecology
research. Trends Biotechnol. 28, 291–299. doi: 10.1016/j.tibtech.2010.03.001
Salazar, N., López, P., Valdés, L., Margolles, A., Suarez, A., Patterson, A. M., et al.
(2013). Microbial targets for the development of functional foods accordingly
with nutritional and immune parameters altered in the elderly. J. Am. Coll. Nutr.
32, 399–406. doi: 10.1080/07315724.2013.827047
Salminen, S., Gibson, G. R., Mccartney, A. L., and Isolauri, E. (2004). Inﬂuence of
mode of delivery on gut microbiota composition in seven year old children. Gut
53, 1388–1389. doi: 10.1136/gut.2004.041640
Solís, G., de los Reyes-Gavilán, C. G., Fernández, N., Margolles, A., and Gueimonde,
M. (2010). Establishment and development of lactic acid bacteria and biﬁdobac-
teria microbiota in breast-milk and the infant gut. Anaerobe 16, 307–310. doi:
10.1016/j.anaerobe.2010.02.004
Sullivan, A., Edlund, C., and Nord, C. E. (2001). Effect of antimicrobial agents on
the ecological balance of human microﬂora. Lancet Infect. Dis. 1, 101–114. doi:
10.1016/S1473-3099(01)00066-4
Tanaka, S., Kobayashi, T., Songjinda, P., Tateyama, A., Tsubouchi, M., Kiyohara, C.,
et al. (2009). Inﬂuence of antibiotic exposure in the early postnatal period on
the development of intestinal microbiota. FEMS Immunol. Med. Microbiol. 56,
80–87. doi: 10.1111/j.1574-695X.2009.00553.x
Tottey, W., Denonfoux, J., Jaziri, F., Parisot, N., Missaoui, M., Hill, D., et al. (2013).
The human gut chip “HuGChip,” an explorative phylogenetic microarray for
determining gut microbiome diversity at family level. PLoS ONE 8:e62544. doi:
10.1371/journal.pone.0062544
Frontiers in Genetics | Nutrigenomics November 2014 | Volume 5 | Article 406 | 8
Salazar et al. Intestinal microbiome at extreme ages
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley,
R. E., et al. (2009). A core gut microbiome in obese and lean twins. Nature 457,
480–484. doi: 10.1038/nature07540
Ursell, L. K., Haiser, H. J., Van Treuren, W., Garg, N., Reddivari, L., Vanamala, J.,
et al. (2014). The intestinal metabolome: an intersection between microbiota and
host. Gastroenterology 146, 1470–1476. doi: 10.1053/j.gastro.2014.03.001
Vallejo, A. N. (2011). Immunological hurdles of ageing: indispensable research of
the human model. Ageing Res. Rev. 10, 315–318. doi: 10.1016/j.arr.2011.01.005
van Baarlen, P., Troost, F., Van Der Meer, C., Hooiveld, G., Boekschoten, M.,
Brummer, R. J., et al. (2011). Human mucosal in vivo transcriptome responses
to three lactobacilli indicate how probiotics may modulate human cellu-
lar pathways. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1), 4562–4569. doi:
10.1073/pnas.1000079107
van den Bogert, B., De Vos, W. M., Zoetendal, E. G., and Kleerebezem, M. (2011).
Microarray analysis and barcoded pyrosequencing provide consistent microbial
proﬁles depending on the source of human intestinal samples. Appl. Environ.
Microbiol. 77, 2071–2080. doi: 10.1128/AEM.02477-10
Videhult, F. K., Ohlund, I., Stenlund, H., Hernell, O., and West, C. E. (2014).
Probiotics during weaning: a follow-up study on effects on body composition and
metabolic markers at school age. Eur. J. Nutr. doi: 10.1007/s00394-014-0715-y
[Epub ahead of print].
Wang, Y., Hoenig, J. D., Malin, K. J., Qamar, S., Petrof, E. O., Sun, J., et al. (2009).
16S rRNA gene-based analysis of fecal microbiota from preterm infants with and
without necrotizing enterocolitis. ISME J. 3, 944–954. doi: 10.1038/ismej.2009.37
WHO. (2009). Infant and Young Child Feeding: Model Chapter for Textbooks for
Medical Students and allied Health Professionals. Geneva: WHO Press.
Winkler, B., Aulenbach, J., Meyer, T., Wiegering, A., Eyrich, M., Schlegel, P. G., et al.
(2014). Formula-feeding is associated with shift towards Th1 cytokines. Eur. J.
Nutr. doi: 10.1007/s00394-014-0693-0 [Epub ahead of print].
Woodmansey, E. J. (2007). Intestinal bacteria and ageing. J. Appl. Microbiol. 102,
1178–1186. doi: 10.1111/j.1365-2672.2007.03400.x
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y. Y., Keilbaugh, S. A.,
et al. (2011). Linking long-term dietary patterns with gut microbial enterotypes.
Science 334, 105–108. doi: 10.1126/science.1208344
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello,
M. G., Contreras, M., et al. (2012). Human gut microbiome viewed
across age and geography. Nature 486, 222–227. doi: 10.1038/nature
11053
Conflict of Interest Statement: The authors declare that the research was conducted
in the absence of any commercial or ﬁnancial relationships that could be construed
as a potential conﬂict of interest.
Received: 10 July 2014; accepted: 02 November 2014; published online: 21 November
2014.
Citation: Salazar N, Arboleya S, Valdés L, Stanton C, Ross P, Ruiz L, Gueimonde M
and de los Reyes-Gavilán CG (2014) The human intestinal microbiome at extreme ages
of life. Dietary intervention as a way to counteract alterations. Front. Genet. 5:406. doi:
10.3389/fgene.2014.00406
This article was submitted to Nutrigenomics, a section of the journal Frontiers in
Genetics.
Copyright © 2014 Salazar, Arboleya, Valdés, Stanton, Ross, Ruiz, Gueimonde and
de los Reyes-Gavilán. This is an open-access article distributed under the terms of the
Creative Commons Attribution License (CC BY). The use, distribution or reproduction
in other forums is permitted, provided the original author(s) or licensor are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
www.frontiersin.org November 2014 | Volume 5 | Article 406 | 9
